gentle waves®
NEWS
RELEASE
For
more information, contact: Nadine Tosk, 504.483.6957
or Nadine@bellsouth.net
FDA CLEARS
GENTLEWAVES® THE FIRST AND ONLY LIGHT EMITTING
DIODE DEVICE FOR THE TREATMENT OF PERIORBITAL WRINKLES AND
RHYTIDS
Gentle Waves® LED Photomodulation® Proven
Effective For
Cosmetic Skin Fitness
“GentleWaves LED Photomodulation is a
fundamentally new approach to improving photoaging and environmentally damaged
skin that does not rely on high-energy sources and heat damage to photoactivate collagen genes,” said Robert A. Weiss, MD,
associate professor of dermatology at Johns Hopkins University School of
Medicine in
GentleWaves uses specially coded arrays
of light emitting diodes to modulate the activity of living cells. Unlike other
laser, pulsed light or radiofrequency techniques used today for skin
rejuvenation, GentleWaves’ exclusive core technology delivers very
low-intensity, non-thermal light energy to stimulate collagen and reverse the
appearance of photoaging, With its proprietary and predetermined energy
sequencing, the easy-to- use device poses no learning curve or risk of
complications. A patient simply sits with his/her face exposed to two panels of
over 2,000 yellow cascading LED lights for less than one minute. The device can
also be adjusted to treat the neck and chest areas. And, for patients seeking a
full program of skin fitness, GentleWaves treatment is complemented by a
scientifically developed line of cosmeceutical
products.
According to lead researcher David H.
McDaniel, MD, the FDA clearance of GentleWaves marks the culmination of years
of rigorous scientific investigation and successful clinical practice by
renowned aesthetic physicians nationwide. “We are proud that we adhered to the
scientific standards the FDA applies to guarantee the efficacy of a new
anti-wrinkle device introduced to today’s appearance-conscious consumers,” said
the director of the
Recognizing the capabilities and benefits
of the GentleWaves System, Rick Krupnick, CEO of LightBioScience, enthusiastically announced his excitement
regarding the regulatory clearance: “The FDA clearance distinguishes
GentleWaves as the first and only LED device to effectively treat periorbital
wrinkles. Today’s announcement of medical marketing claims allows us to meet a
growing demand from patients who have been waiting for a gentle, pain-free skin
fitness regime without side effects, downtime or a huge investment,”
To assess the safety and efficacy of
GentleWaves, the FDA reviewed data from a multi-center clinical study of 54
patients. After 8 GentleWaves treatments, over 50% of all patients showed
measurable improvement in periorbital wrinkle reduction. Further, of those with
more severe wrinkles (category 6-8), 94% exhibited measurable improvement.
About Light BioScience
Light BioScience, LLC is the leader in
the science of LED Photomodulation, a groundbreaking light- based technology
for medical and aesthetic applications, Its flagship GentleWaves LED
Photomodulation System provides a safe and effective non-invasive and
non-ablative solution to photoaging and includes a complete skin care regimen
featuring cosmeceuticals that are
dermatologist-tested and intended for all skin types. The Company is actively
researching other clinical uses of the GentleWaves platform technology,
including applications to improve acne, sunburn and wound healing.
Based
in
For
more information, please visit www.lightbioscience.com.
933 First colonial Road,
www.lightbioscience.com •
mail@lightbioscience.com